Ben Atkins
Keine laufenden Positionen mehr
Profil
Ben Atkins worked as the VP of Communications & Investor Relations at Opiant Pharmaceuticals, Inc..
Mr. Atkins attended King's College London for his undergraduate degree.
Ehemalige bekannte Positionen von Ben Atkins
| Unternehmen | Position | Ende |
|---|---|---|
| OPIANT PHARMACEUTICALS, INC. | Investor Relations Kontakt | 02.03.2023 |
Ausbildung von Ben Atkins
| King's College London | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
